Implant one sheet of PAL-222 into the subretinal space through pars plana vitrectomy

2 trials

Sponsors

Kusano Hitoshi

Conditions

Myopic chorioretinal atrophyNeovascular Age-related Macular Degeneration (AMD) that shows no response to existing therapy

Phase 2

Phase I/IIa clinical study of PAL-222 targeting patients with myopic chorioretinal atrophy

Active, not recruitingJPRN-jRCT2043220105

Kusano HitoshiMyopic chorioretinal atrophy

Start: 2023-02-17Target: 10Updated: 2026-06-29

Progression Suppression and Retinal Regression in VEGF-resistant AMD

RecruitingJPRN-jRCT2063240083

Kusano HitoshiNeovascular Age-related Macular Degeneration (AMD) that shows no response to existing therapy

Start: 2025-02-25Target: 10Updated: 2026-06-29